Abstract |
We have examined the intranasal administration of a vaccine against Mycobacterium tuberculosis (M.tb) consisting of the mucosal adjuvant LTK63 and the Ag Ag85B-ESAT-6. Vaccination with LTK63/Ag85B-ESAT-6 gave a strong and sustained Th1 response mediated by IFN-gamma-secreting CD4 cells, which led to long-lasting protection against tuberculosis, equivalent to that observed with bacillus Calmette-Guérin (BCG) or Ag85B-ESAT-6 in dimethyldioctadecylammonium bromide/ monophosphoryl lipid A. Because a crucial element of novel vaccine strategies is the ability to boost BCG-derived immunity, we also tested whether LTK63/Ag85B-ESAT-6 could act as a BCG booster vaccine in BCG-vaccinated mice. We found that vaccinating with LTK63/Ag85B-ESAT-6 strongly boosted prior BCG-stimulated immunity. Compared with BCG-vaccinated nonboosted mice, we observed that infection with M.tb led to a significant increase in anti-M.tb-specific CD4 T cells in the lungs of LTK63/Ag85B-ESAT-6-boosted animals. This correlated with a significant increase in the protection against M.tb in LTK63/Ag85B-ESAT-6-boosted mice, compared with BCG-vaccinated animals. Thus, LTK63/Ag85B-ESAT-6 represents an efficient preventive vaccine against tuberculosis with a strong ability to boost prior BCG immunity.
|
Authors | Jes Dietrich, Claire Andersen, Rino Rappuoli, T Mark Doherty, Charlotte Green Jensen, Peter Andersen |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 177
Issue 9
Pg. 6353-60
(Nov 01 2006)
ISSN: 0022-1767 [Print] United States |
PMID | 17056566
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Bacterial
- Bacterial Proteins
- Bacterial Toxins
- ESAT-6 protein, Mycobacterium tuberculosis
- Enterotoxins
- Escherichia coli Proteins
- Recombinant Fusion Proteins
- Tuberculosis Vaccines
- heat-labile enterotoxin, E coli
- Acyltransferases
- antigen 85B, Mycobacterium tuberculosis
|
Topics |
- Acyltransferases
(administration & dosage, immunology)
- Administration, Intranasal
- Animals
- Antigens, Bacterial
(administration & dosage, immunology)
- Bacterial Proteins
(administration & dosage, immunology)
- Bacterial Toxins
(administration & dosage, immunology)
- Enterotoxins
(administration & dosage, immunology)
- Escherichia coli Proteins
(administration & dosage, immunology)
- Immunization, Secondary
- Mice
- Mice, Inbred Strains
- Mycobacterium bovis
(immunology)
- Mycobacterium tuberculosis
- Nasal Mucosa
(immunology)
- Recombinant Fusion Proteins
(administration & dosage, immunology)
- T-Lymphocytes
(immunology)
- Tuberculosis Vaccines
(administration & dosage, immunology, therapeutic use)
- Tuberculosis, Pulmonary
(prevention & control)
- Vaccination
|